Sign in
MBCI Stock Price, Chart, Stats & News
MabCure Inc.
Save
MabCure Inc. (MBCI) does not currently pay a dividend.
21,965
Market cap
–
Current P/E
–
Forward P/E
MBCI chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan.
Similar securities
Based on sector and market capitalization
Report issue